A BIOCOMPATIBLE NANOPARTICLE-BASED APPROACH TO INHIBITING RENAL ISCHEMIA REPERFUSION INJURY IN MICE BY BLOCKING THROMBOSPONDIN-1 ACTIVITY. Issue 3 (September 2020)